|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Celecoxib (CELEBREX, generics) - as safe as naproxen and ibuprofen regarding cardiovascular events?
Prevention of thromboembolism after knee arthroscopy or lower-leg casting
Rivaroxaban for patients with atrial fibrillation undergoing placement of stents: doubtful benefits compared with warfarin
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Adjuvanted flu vaccine FLUAD … clinical efficacy benefits still not proven
Carotis plaques detected by screening in healthy people - what should you do?
Restrict package size for colchicine preparations
|
|
|
IN BRIEF
|
|
USA: warning notice for homoeopathics
Pfizer/UK: 100 million € fine because of high prices
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Angioedema and other intolerance reactions with oral lavendula oil (LASEA)
|
|
|
SIDE EFFECTS
|
|
Unusual coloured urine due to drugs
|
|
|
e a-t IN THE INTERNET
|
|
Hepatitis C: sofosbuvir plus velpatasvir (EPCLUSA)
|
|